Treatment Paradigms for Advanced Non‐Small Cell Lung Cancer at Academic Medical Centers: Involvement in Clinical Trial Endpoint Design

Based on the positive results of various clinical trials, treatment options for non‐small cell lung cancer (NSCLC) have expanded greatly over the last 25 years. While regulatory approvals of chemotherapeutic agents for NSCLC have largely been based on improvements in overall survival, recent approva...

Descripción completa

Detalles Bibliográficos
Autores principales: Aggarwal, Charu, Borghaei, Hossein
Formato: Online Artículo Texto
Lenguaje:English
Publicado: AlphaMed Press 2017
Materias:
Lung Cancer
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5469580/
https://www.ncbi.nlm.nih.gov/pubmed/28408617
http://dx.doi.org/10.1634/theoncologist.2016-0345

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5469580/
https://www.ncbi.nlm.nih.gov/pubmed/28408617
http://dx.doi.org/10.1634/theoncologist.2016-0345

Ejemplares similares